tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market

Ikena Oncology (IKNA) Financial Statements

94 Followers

Ikena Oncology Financial Overview

Ikena Oncology's market cap is currently ―. The company's EPS TTM is $-1.577; its P/E ratio is -1.08; Ikena Oncology is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 659.00K$ 1.19M$ 2.00M$ 5.31M
Gross Profit-$ 658.00K$ 1.19M$ 2.00M$ 5.31M
EBIT$ -15.64M$ -21.91M$ -17.34M$ -17.11M$ -14.95M
EBITDA$ -15.43M$ -21.60M--$ -15.25M
Net Income Common Stockholders$ -16.15M$ -19.49M$ -17.34M$ -17.11M$ -14.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.35M$ 175.47M$ 196.93M$ 157.31M$ 137.81M
Total Assets$ 172.78M$ 192.09M$ 215.34M$ 171.76M$ 152.40M
Total Debt$ 9.74M$ 11.69M$ 12.34M$ 4.99M$ 5.35M
Net Debt$ -147.60M$ -163.78M$ -184.59M$ -152.32M$ -132.46M
Total Liabilities$ 17.43M$ 22.34M$ 28.15M$ 15.06M$ 17.38M
Stockholders Equity$ 155.35M$ 169.76M$ 155.34M$ 156.70M$ 135.02M
Cash Flow-
Free Cash Flow$ -18.24M$ -22.09M--$ -19.94M
Operating Cash Flow$ -18.30M$ -21.82M$ -20.00M-$ -19.78M
Investing Cash Flow$ -48.74M$ 20.38M$ 31.89M-$ -10.81M
Financing Cash Flow-$ 60.00K$ 38.92M--
Currency in USD

Ikena Oncology Earnings and Revenue History

Ikena Oncology Debt to Assets

Ikena Oncology Cash Flow

Ikena Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis